BVT.13

SKU: orb1702465

Description

BVT.13 is a potent and selective oral PPARγ agonist with antidiabetic efficacy. It demonstrates full agonist activity comparable to rosiglitazone in vitro and reduces hyperglycemia in ob/ob mouse models, supporting its use in diabetes and metabolic syndrome research.

Research Area

Metabolism Research, Molecular Biology

Key Properties

• CAS Number: 756813-87-3
• MW: 404.2
• Formula: C₁₈H₁₁Cl₂N₃O₄
• SMILES: N(C(=O)C1=C(Cl)C=C(Cl)C=C1)C2=C(C(O)=O)C=C(OC=3N=CC=CN3)C=C2
• Target: Others
• Solubility: DMSO:3.2 mg/mL (7.92 mM)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

BVT 13, BVT.13, BVT13, BVT-13

Compound Identifiers

PubChem CID

5289162